Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Autoimmune Treatment Market Value Growth And Long-Term Outlook
The autoimmune treatment market has experienced rapid expansion in recent years. Its valuation is anticipated to climb from $8.63 billion in 2025 to $9.84 billion in 2026, reflecting a compound annual growth rate (CAGR) of 14.0%. Historically, this growth can be attributed to the improved availability of immunosuppressive drugs, the expansion of rheumatology and immunology services, accumulating clinical experience in autoimmune care, increased patient diagnosis rates, and wider access to specialty medications.
The autoimmune treatment market size is projected to experience swift expansion in the coming years. This market is set to reach $16.53 billion by 2030, driven by a compound annual growth rate (CAGR) of 13.9%. Factors contributing to this growth during the projected period include greater investment in the creation of new biologics, a heightened need for individualized autoimmune treatments, the broadening of digital monitoring and aftercare services, an intensified effort to mitigate long-term complications of diseases, and increased exploration into modulating the immune system. Key trends anticipated for the forecast period encompass a wider embrace of biologic therapies, an uptick in the application of targeted immunomodulators, the broader incorporation of long-term disease management initiatives, the proliferation of tailored treatment plans, and a greater emphasis on combination drug approaches.
Get A Free Sample Report With In-Depth Market Insights:
Autoimmune Treatment Market Growth Catalysts And Demand Drivers
The expanding healthcare expenditures are anticipated to fuel the growth of the autoimmune treatment market. Healthcare expenditures encompass all expenses linked to delivering health services, family planning efforts, nutritional programs, and health-oriented emergency assistance. An uplift in healthcare spending is expected to result in the development of more effective treatments and medical advancements for autoimmune conditions. For instance, data from the Office for Budget Responsibility (OBR) and Treasury’s economic forecast indicates that the UK’s planned health expenditure is set to rise to £192 billion ($244.43 billion) in 2024/25, increasing from £182 billion ($231.70 billion) in 2022/23. Likewise, the National Health Expenditures Accounts (NHEA) from KFF, a US-based independent health policy research organization, projects that health spending in the United States will climb by 5% between 2023 and 2024, reaching $4.9 trillion. Consequently, the uptick in healthcare expenditures is acting as a significant driver for the expansion of the autoimmune treatment market.
Autoimmune Treatment Market Segment Outlook: Which Categories Are Growing Fastest?
The autoimmune treatment market covered in this report is segmented –
1) By Service Type: Consultation And Diagnosis, Therapy And Monitoring, Drug development
2) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases
3) By Application: Disease Management and Symptom Control, Disease Diagnosis and Monitoring, Immune Modulation and Targeted Therapy, Long-Term Care and Relapse Prevention
Subsegments:
1) By Consultation and Diagnosis: Clinical Evaluation and Medical Consultation, Autoimmune Biomarker Testing and Serological Assays, Imaging and Functional Diagnostic Services, Disease Severity Assessment and Risk Stratification
2) By Therapy and Monitoring: Pharmacological Treatment Management, Biologic and Immunotherapy Administration, Disease Activity Monitoring and Follow-Up Services, Adverse Event and Safety Monitoring, Patient Support and Adherence Programs
3) By Drug Development: Preclinical Research and Target Identification, Clinical Trial Services (Phase I–IV), Regulatory Affairs and Compliance Services, Pharmacovigilance and Post-Marketing Surveillance
Autoimmune Treatment Market Trends Shaping Long-Term Demand
Major companies active in the autoimmune treatment market are increasingly focusing on introducing innovative clinical trial platforms to gain a competitive advantage. These innovative clinical trial platforms in autoimmune treatment harness advanced technologies and personalized approaches to enhance efficacy, safety, and patient outcomes. For instance, in August 2023, the Scleroderma Research Foundation, a US-based non-profit organization, launched the CONQUEST trial platform. The CONQUEST program aims to advance research and treatments for scleroderma, a rare autoimmune disease that affects connective tissues. It addresses crucial issues in clinical development and enables progress in scleroderma therapeutics. The CONQUEST platform clinical trial is the first of its kind in rare autoimmune diseases, designed to quickly evaluate potential treatments for interstitial lung disease associated with systemic sclerosis (SSc-ILD) as well as global SSc outcomes, including some focused on skin and other aspects of the disease.
Autoimmune Treatment Market Leading Companies And Competitive Benchmarking
Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Eli Lilly and Company, Pfizer Inc., F Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Biogen Idec Inc., GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Cabaletta Bio Inc., ChemoCentryx Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited
View The Full Autoimmune Treatment Market Report:
Autoimmune Treatment Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the autoimmune treatment market in 2025. The regions covered in the autoimmune treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.